A5087928810- Prostate Cancer Diagnosis and Treatment
- Urinary Bladder and Prostate Research
- Liver Disease and Transplantation
- Organ Transplantation Techniques and Outcomes
- Urological Disorders and Treatments
- Urologic and reproductive health conditions
- Liver Disease Diagnosis and Treatment
- Hormonal Regulation and Hypertension
- Transplantation: Methods and Outcomes
- Adrenal and Paraganglionic Tumors
- Vascular Procedures and Complications
- Venous Thromboembolism Diagnosis and Management
- Pelvic floor disorders treatments
- Gallbladder and Bile Duct Disorders
- Central Venous Catheters and Hemodialysis
- Pediatric Hepatobiliary Diseases and Treatments
- Abdominal vascular conditions and treatments
- Renal and Vascular Pathologies
- Hepatocellular Carcinoma Treatment and Prognosis
- Pancreatic and Hepatic Oncology Research
- Adrenal Hormones and Disorders
- Cardiac pacing and defibrillation studies
- Radiation Dose and Imaging
- Metabolism and Genetic Disorders
- Organ Donation and Transplantation
Hospital Sírio-Libanês
2013-2025
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2015-2024
Universidade de São Paulo
2014-2024
Hospital São Paulo
2012-2021
Instituto do Câncer do Estado de São Paulo
2015-2020
Society of Interventional Radiology
2013
American Association of Neurological Surgeons
2013
American College of Radiology
2013
American Society of Neuroradiology
2013
AC Camargo Hospital
2009-2012
Symptomatic benign prostatic hyperplasia (BPH) typically occurs in the sixth and seventh decades, most frequent obstructive urinary symptoms are hesitancy, decreased stream, sensation of incomplete emptying, nocturia, frequency, urgency. Various medications, specifically 5-alpha-reductase inhibitors selective alpha-blockers, can decrease severity secondary to BPH, but prostatectomy is still considered be traditional method management. We report preliminary results for two patients with acute...
Background Long-term experience with prostatic artery embolization (PAE) for benign hyperplasia remains limited. Purpose To evaluate the efficacy, safety, and long-term results of PAE hyperplasia. Materials Methods This retrospective single-center study was conducted from June 2008 to 2018 in patients moderate severe hyperplasia-related symptoms. International Prostate Symptom Score (IPSS), quality-of-life score, maximum urinary flow rate, postvoid residual volume, prostate-specific antigen...
The purpose of this article is to assess and describe the MRI findings after prostatic artery embolization for treatment benign hyperplasia.We retrospectively evaluated 17 patients who underwent as part different prospective studies evaluate alternative hyperplasia. Clinical results were by assessment urinary catheterization International Prostate Symptom Score (IPSS). Serial examinations performed, central gland peripheral zone signal intensity changes presence characteristics infarcted...
The availability of living donors allows transplant teams to indicate donor liver transplantation (LDLT) early in the course disease before occurrence life-threatening complications. Late referral centers is still a problem and can compromise success procedure. aim this study was examine perioperative factors associated with patient graft survival for 430 consecutive pediatric LDLT procedures at Sirio-Libanes Hospital/A. C. Camargo Hospital (São Paulo, Brazil) between October 1995 April...
The incidence of biliary complications (BCs) after living donor liver transplantation (LDLT) can reach 40%. Published data on the pediatric population are limited, and treatment protocols vary. Our aim was to describe clinical scenario for BCs approaches LDLT. Between October 1995 December 2012, 489 LDLT procedures were performed. developed in 71 patients (14.5%). Biliary strictures (BSs) 45 (9.2%) patients, bile leaks (BLs) 33 (6.7%). BL diagnosis all cases, 69.7% underwent surgery. Nearly...